Advaxis Inc.

Advaxis Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
52.83 M
Public Float
41.4 M
Advaxis Inc.
Stock Exchange NASDAQ Stock Market
EPS
$7.26
Market Cap
$14.36 M
Shares Outstanding
8.01 M
Public Float
64.28 M

Profile

Address
305 College Road East
Princeton New Jersey 08540
United States
Employees -
Website http://www.advaxis.com
Updated 07/08/2019
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy.

Financials

View All

David Sidransky
Chairman
Kenneth A. Berlin
President, Chief Executive Officer & Director